Mainz Biomed (MYNZ) EPS (Weighted Average and Diluted) (2022 - 2023)
Historic EPS (Weighted Average and Diluted) for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $66.14.
- Mainz Biomed's EPS (Weighted Average and Diluted) rose 19031.82% to $66.14 in Q4 2023 from the same period last year, while for Dec 2023 it was $64.74, marking a year-over-year increase of 18902.64%. This contributed to the annual value of -$22.36 for FY2024, which is 13452.75% down from last year.
- Per Mainz Biomed's latest filing, its EPS (Weighted Average and Diluted) stood at $66.14 for Q4 2023, which was up 19031.82% from -$0.39 recorded in Q3 2023.
- Over the past 5 years, Mainz Biomed's EPS (Weighted Average and Diluted) peaked at $66.14 during Q4 2023, and registered a low of -$73.23 during Q4 2022.